Literature DB >> 15923043

Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up.

Köksal Alptekin1, Sahap Erkoç, Ali K Göğüş, Savaş Kültür, Levent Mete, Alp Uçok, Kazim M Yazici.   

Abstract

Schizophrenia may cause disability leading to restrictions on many domains of daily life such as hygiene, self-management, vocational and leisure activities, and family and social relationships. The aim of this study was to assess the level of disability with the Brief Disability Questionnaire (BDQ), developed by the World Health Organization, and to identify the clinical correlates and predictors of disability during a 1-year follow-up period in 382 patients with schizophrenia. All patients were assessed at the beginning of the study, and 168 (44%) of them were re-evaluated after 1 year. Total disability scores of the patients with schizophrenia were significantly decreased at follow-up. Female patients seemed to be more disabled than males. Disability showed a positive correlation with the total, positive symptoms and negative symptoms scores on the Brief Psychiatric Rating Scale, as well as scores on the UKU Side Effects Rating Scale. Patients with the disorganized subtype of schizophrenia and residual symptoms were more disabled than patients with other subtype diagnoses. Negative symptoms and duration of untreated psychosis were significant predictors of disability after 1 year. Early-onset schizophrenia had a twofold increased risk for developing disability. Disability in schizophrenia is a clinical phenomenon closely linked to negative symptoms and poor outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15923043     DOI: 10.1016/j.psychres.2004.05.027

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Ilja Spellmann; Richard Musil; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

2.  Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Florian Seemüller; Hans-Jürgen Möller
Journal:  Psychiatr Q       Date:  2012-06

3.  Disability in clinically stable patients of schizophrenia.

Authors:  Mahaprakash Sharma; Anil Nischal; Anuradha Nischal; Manu Agarwal; Bandna Gupta; Sujit Kumar Kar; Erika Pahuja
Journal:  Ind Psychiatry J       Date:  2020-11-07

4.  Prevalence and risk factors of psychotic symptoms: in the city of Izmir, Turkey.

Authors:  Köksal Alptekin; Halis Ulas; Berna Binnur Akdede; Mevhibe Tümüklü; Yildiz Akvardar
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-03       Impact factor: 4.328

5.  Psychosocial disabilities in patients with schizophrenia.

Authors:  Ma Goreishizadeh; A Mohagheghi; S Farhang; L Alizadeh
Journal:  Iran J Public Health       Date:  2012-05-31       Impact factor: 1.429

6.  Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence.

Authors:  William Ak-Lam Lo; Daniel Ki-Yan Mak; Michael Ming-Cheuk Wong; Oi-Wah Chan; Eileena Mo-Ching Chui; Dicky Wai-Sau Chung; Glendy Suk-Han Ip; Ka-Shing Lau; Che-Kin Lee; Jolene Mui; Ka-Lok Tam; Samson Tse; Kwong-Lui Wong
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243

7.  Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?

Authors:  Sirijit Suttajit; Suwanna Arunpongpaisal; Manit Srisurapanont; Nuntika Thavichachart; Ronnachai Kongsakon; Sunanta Chantakarn; Vasu Chantarasak; Apichat Jariyavilas; Piyadit Jaroensook; Khanogwan Kittiwattanagul; Osot Nerapusee
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-29       Impact factor: 2.570

8.  A study of profile of disability certificate seeking patients with schizophrenia over a 5 year period.

Authors:  Yatan Pal Singh Balhara; Rohit Verma; Smita N Deshpande
Journal:  Indian J Psychol Med       Date:  2013-04

9.  Disability assessment as an outcome measure: a comparative study of Nigerian outpatients with schizophrenia and healthy control.

Authors:  Adesanmi Akinsulore; Boladale M Mapayi; Olutayo O Aloba; Ibidunni Oloniniyi; Femi O Fatoye; Roger O A Makanjuola
Journal:  Ann Gen Psychiatry       Date:  2015-11-23       Impact factor: 3.455

10.  The magnitude of disability in patients with schizophrenia in North West Ethiopia: A multicenter hospital-based cross-sectional study.

Authors:  Getnet Mihretie Beyene; Getasew Legas; Telake Azale; Mebrat Abera; Sintayehu Asnakew
Journal:  Heliyon       Date:  2021-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.